Total funding amount: Up to £65K across the entire fellowship.

Award duration: 1 year or longer if Less Than Full Time (LTFT). LTFT must be no less than 50% of the full-time equivalent.

Application deadline: 15 May 2026 (12:00 PM) (for expression of interest).

As one of the few registered charities dedicated to addressing the most significant funding gaps in musculoskeletal (MSK) health research, we must continue to invest in the future of our field — and that future lies in supporting Early Career Researchers (ECRs). Strengthening the talent pipeline is essential if we are to generate the discoveries, innovations, and clinical impact that MSK health urgently requires.

Our focus is on supporting early career researchers who wish to pursue work within the activity areas defined in the UKCRC Health Research Analysis 2022. These areas represent the core foundations of MSK research and the greatest opportunities to create long‑term impact:

• Underpinning: understanding biological, psychological and socioeconomic processes.
• Aetiology: risks, causes and development of health conditions.
• Prevention: interventions to prevent disease, promote wellbeing and reduce risks of ill health.
• Detection and Diagnosis: population screening, using new diagnostic technologies and biomarker discovery and development.
• Treatment Development: translating basic research into experimental medicine in preclinical settings and/or model systems.
• Treatment Evaluation: testing and evaluating interventions in human clinical/applied settings.
• Disease Management: understanding patient needs and practitioner experiences.
• Health Services: examining healthcare at an organisational level, such as service provision and economic and policy issues.

The research we fund should aim to enhance the quality of life for people living with MSK conditions across joints, bones, muscles, or multiple body areas. Our priority is to back work that can move rapidly from ideas to practical solutions. By supporting Early Career Researchers, we aim to accelerate projects with the potential to transform clinical practice and improve outcomes at scale and at speed.

Impact can take many forms – from improving clinical processes and pathways to developing new products, tools, or services. What matters most is that the research has a credible path to real‑world benefit and the potential to positively influence the way clinicians work and how patients experience care.

The breadth of possible research topics include:

• AI / Big data / Digital technology / Computational modelling
• Cell, bone and soft tissue biology
• Biomaterials, biomechanics, prosthetic and surgical devices
• Hip
• Knee
• Osteoarthritis
• Pain
• Bone fractures
• Spine / Back
• Paediatric care
• Co-morbidity
• Foot & Ankle
• Shoulder
• Trauma and Orthopaedic surgery
• Bone cancer
• Rehabilitation & Exercise
• Hand & Wrist
• Rheumatic Arthritis
• Infection
• Fibromyalgia
• General MSK health awareness

The purpose of the fund

The Early Career Research Fellowship is designed to support the brightest and best clinical/nonclinical talents interested in advancing MSK research in the UK by:

• Funding of up to £65K over 1 year or longer if LTFT.
• Helping establish researchers’ academic independence and international reputation.
• Developing ambassadors for ORUK and supporting them to become future MSK leaders.

Application process

Stage 1: Research Committee Review – Expression of Interest

The short expression of interest (EoI) form is designed to make the selection process at the early stage easier. The online form will allow researchers to convey the societal need for their research as clearly as possible.

No specific feedback will be generated at the end of this stage to either successful or rejected proposals other than confirming the decision of the Research Committee.

Please note that there will not be an appeal process in place to reverse the decision of the Research Committee. The EoI form must be submitted online.

Stage 2: External Expert Review – Full Application

The full application form will be emailed to the successful applicants after 15 June 2026.

All applicants are required to use scientific language and include images where appropriate, in addition to providing the necessary references to support their claims.

The applicants are encouraged to suggest up to five names of external experts within their research field to review their proposal. These external experts must not be linked to their application and ORUK will not guarantee that these individuals will be invited to review. More details can be found in our Conflicts of Interest policy.

Multiple external experts will be invited to review the full applications. External experts will be asked to use a scoring system to rate the scientific quality of research. At the end of this stage, applications will be ranked according to the scores received by the external experts. Those qualified or rejected at this stage will be notified via e- mail.

Applicants of the rejected proposals will receive their score along with any specific feedback that may have been provided by the external experts.

Those qualified at this stage will then be forwarded on to the Scientific Advisory Committee for further evaluation.

Accompanying their full application, the applicants are required to enclose CVs for all the stakeholders involved. The format of the files can be in both PDF (.pdf) or Word (.docx). For CVs, all files should be titled as following: “Name of researcher_CV.pdf”.

Stage 3: Scientific Advisory Committee Review

The Scientific Advisory Committee (SAC) normally meets up once a year to review and recommend the best MSK research that can make a positive impact on patients’ lives.

Applicants are required to appear before this committee, give a short presentation and take part in a Q&A session.

The same scoring system used by the external experts is applied to assess each application. Recommendations of the SAC will then be forwarded to the Board of Trustees.

Stage 4: ORUK Board of Trustees

The Board receives the recommendations of the SAC, and depending on the budget and additional information received, awards research grants and investments.

Assessment criteria

Applicants will be assessed on the following criteria and are also expected to provide details on Intellectual Property and testing on animals, if applicable.

• Purpose of research: research aims, objectives and deliverables.
• Background to investigation: brief literature review, personal track record and preliminary data obtained by the applicant(s).
• Plan of investigation, covering materials & methods: a detailed technical step-by-step research plan, according to linked work packages. and focusing on the core ideas and methodologies.
• Research environment and resources: research clinical/technical support, laboratory space, equipment and any other additional fundings.
• Research impact:
  • Who will benefit from this research?
  • How can your research be translated into care or treatment for patients?
  • How will your research represent the aims and objectives of ORUK?
• Outreach and engagement.
• Research budget: full cost breakdown.

What are the key dates?

Recipient requirements

• Contract: The applicants must share the with their respective University /Trust’s Research Contracts Department and agree in principle with our Standard Research Agreement terms and conditions.
• Progress report: Every 6 months, the successful ORUK Fellows are asked to submit an interim report, covering their research progress and details of publications and presentations.
• Engagement: It is expected that the successful Fellows will support ORUK with public engagement, annual reports and publications, as well as fundraising campaigns (if any).
• The financial and non-financial support of ORUK must be duly acknowledged in all the presentations and publications by the Fellows.

AI Based Application Success Predictor

🦴 1. Strong Focus on Musculoskeletal & Orthopaedic Conditions (Non-Negotiable)

• Projects must directly address:
  • Bone, joint, and musculoskeletal disorders
• Common areas:
  • Osteoarthritis
  • Trauma & fracture healing
  • Joint replacement
  • Spine disorders

👉 Weak orthopaedic relevance → low success probability

🔄 2. Translational & Innovation Focus (Top Predictor)

• ORUK explicitly prioritizes:
  • Translational research (lab → clinic)
  • Innovation that can be applied in practice

👉 Key question:
“Will this lead to a new or improved treatment or intervention?”

🎯 3. Clear Patient Impact (Critical)

Successful proposals:

• Demonstrate:
  • Improvement in patient outcomes or quality of life
• Focus on:
  • Reducing pain
  • Improving mobility
  • Enhancing recovery

🚀 4. Strong Emphasis on Commercialization Potential

Unique to ORUK:

• Preference for:
  • Projects with pathway to commercialization
• Includes:
  • Devices
  • Biomaterials
  • Digital health tools

👉 Industry translation is a major differentiator

🧪 5. Feasible, Milestone-Driven Project Design

• Must include:
  • Clear objectives
  • Defined milestones
  • Realistic timelines

👉 Projects should show progression toward application or market

👩‍🔬 6. Investigator Capability & Multidisciplinary Teams

• Strong proposals include:
  • Clinicians + engineers + scientists
• Demonstrated ability to:
  • Deliver translational outcomes

👉 Multidisciplinary teams are highly valued

🤝 7. Collaboration with Industry or Clinical Partners

• Higher success for:
  • Academic–industry partnerships
• Demonstrates:
  • Real-world applicability

📊 8. Evidence of Preliminary Data

• Not always mandatory, but beneficial:
  • Pilot data
  • Proof-of-concept results

👉 Strengthens feasibility and credibility

🌍 9. Alignment with UK Healthcare Needs

• Preference for:
  • Projects relevant to:
    • NHS priorities
• Focus on:
  • Cost-effective solutions

👉 Health system relevance improves competitiveness

💰 10. Realistic Budget & Deliverables

• Funding is typically:
  • Moderate-scale (pilot to mid-size projects)
• Budget must be:
  • Justified
  • Linked to milestones

📊 Summary: Key Predictors (Ranked)

Highest impact factors:

1. Orthopaedic focus
2. Translational innovation
3. Patient impact

Moderate predictors:
4. Commercialization potential
5. Feasibility & milestones
6. Multidisciplinary team

Supporting factors:
7. Collaboration
8. Preliminary data
9. Budget clarity

💡 Insider Insight

Compared to other orthopaedic funders:

• Orthopaedic Research UK is:
  👉 innovation-driven + commercialization-focused
  👉 sits between academic funding and industry translation

👉 Key evaluation question:
“Will this research translate into a practical solution that benefits patients and healthcare systems?”